These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24220240)

  • 1. 6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.
    Li H; Zhu F; Chen H; Cheng KW; Zykova T; Oi N; Lubet RA; Bode AM; Wang M; Dong Z
    Cancer Res; 2014 Jan; 74(1):243-52. PubMed ID: 24220240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
    Yao M; Zhou W; Sangha S; Albert A; Chang AJ; Liu TC; Wolfe MM
    Clin Cancer Res; 2005 Feb; 11(4):1618-28. PubMed ID: 15746067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitors in colorectal cancer.
    Stoehlmacher J; Lenz HJ
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):10-6. PubMed ID: 12802790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
    Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
    J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ; Halton DE; Crew TE; Paraskeva C
    Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
    Sinicrope FA
    Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
    Piazza GA; Keeton AB; Tinsley HN; Gary BD; Whitt JD; Mathew B; Thaiparambil J; Coward L; Gorman G; Li Y; Sani B; Hobrath JV; Maxuitenko YY; Reynolds RC
    Cancer Prev Res (Phila); 2009 Jun; 2(6):572-80. PubMed ID: 19470791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam inhibits the growth of colorectal cancer cells.
    Goldman AP; Williams CS; Sheng H; Lamps LW; Williams VP; Pairet M; Morrow JD; DuBois RN
    Carcinogenesis; 1998 Dec; 19(12):2195-9. PubMed ID: 9886578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
    Zhao Y; Fan D; Ru B; Cheng KW; Hu S; Zhang J; Li ET; Wang M
    Eur J Cancer; 2016 Nov; 68():38-50. PubMed ID: 27710830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects.
    Mohammed SI; Dhawan D; Abraham S; Snyder PW; Waters DJ; Craig BA; Lu M; Wu L; Zheng R; Stewart J; Knapp DW
    Mol Cancer Ther; 2006 Feb; 5(2):329-36. PubMed ID: 16505106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
    Doherty GA; Murray FE
    Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.